BOC and CryoCath launch new technology to fight heart disease in Europe

A partnership between BOC and a Canadian company will see groundbreaking medical technology used to cure cardiovascular disease being made available throughout Europe.The technology, which uses freezing temperatures to treat diseased tissue of patients with irregular heartbeats, has been developed by Montreal-based CryoCath Technologies, and has been successfully launched in ...

You must be a subsciber to read this content

If you already subscribe, please sign-in now

Subscribe to Gas World

 

Get instant access to must-read content today!

To access hundreds of features, subscribe today! At a time when the world is forced to go digital more than ever before just to stay connected, discover the in-depth content our subscribers receive every month by subscribing to gasworld.

Don’t just stay connected, stay at the forefront – join gasworld and become a subscriber to access all of our must-read content online from just $270.